Director- RWD Scientist

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters.

Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.

This is hard, urgent, selfless work-but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

The Director, RWD Scientist will be an integral leader in our evidence generation strategy in Cardiometabolic Health (CMH). Using their knowledge and expertise in real-world data, analytics, and outcomes research, this leader will translate scientific ideas into tangible actions and solutions. The leader in this role is proficient in the technical aspects of RWD sources including claims and health records data and has hands on experience designing and executing studies using RWD.

In addition, the Director, RWD Scientist will need to engage credibly with scientists and senior leadership on methods, implementation, and interpretation of real-world evidence and can lead operational execution of complex studies on traditional, as well as bespoke, sources of data. The role carries responsibility not just for executing today’s RWD agenda, but for also anticipating what the field will require in three to five years and positioning Lilly to lead it.

This includes maximizing the value of AI and emerging technologies into the RWD workflow, building federated and privacy-preserving data capabilities, connecting RWD insights to clinical trial design and regulatory strategy, and ensuring Lilly's data assets reflect the diversity and complexity of real-world patient populations. This is a critical role requiring strong internal partnership, scientific credibility, and the ability to balance uncompromising adherence to standards and best practices with a need for urgency and rapid innovation.

Drives sustained integration of HEOR from early clinical development through commercialization. Develops and oversees HO research strategy for compounds in the Lilly portfolio in the relevant therapeutic area(s). Serves as a strategic partner on lead/core teams throughout development and/or commercialization. Formulates and drives Patient Focused Outcome, Real World Evidence, and/or economic value strategies for priority products and geographies.

Develops bold high impact science for products across the lifecycle, to influence and support evidence needs for Lilly products in support of improving patient outcomes. Applies technical expertise appropriate for the role (e.g., scope or depth in statistical analysis, economic modeling, clinical trials, PFO development, observational/ epidemiologic research, and health technology or other value assessment) within a therapeutic area. Applies disease state knowledge and research methods to solve HO issues associated with registration, pricing, reimbursement, and access initiatives.

Links technical expertise with business acumen and establishes and maintains strategic relationships with key internal and external decision makers. Effectively leads HO evidence planning and implementation in collaboration with cross-functional teams across the development and commercialization lifecycle teams. Effectively integrates with and influences key business partners & external stakeholders to achieve goals and outcomes.

Effectively communicates HO information to internal business partners, the scientific community, and customers. Drives research dissemination strategies and leads research communication efforts including abstracts, posters, podium presentations, promotional materials, and manuscripts.

Maintains awareness of significant developments in disease states in the Lilly portfolio and HO field including current HO methodologies and applications and other issues as appropriate for the position. Anticipates and evaluates future market needs and trends for HO information within pertinent therapeutic area and geography of interest. Monitors & influences internal & external environmental factors that shape and impact generation and use of HO research.

Ensures HO projects meet timelines, budget, and scope by coordinating research efforts with cross-functional Lilly business partners and external collaborators as appropriate.

• Doctorate (PhD, MD) in appropriate discipline (e.g., economics, epidemiology, medicine, pharmacoeconomic, statistics, data science or other relevant sciences) with 5+ years of experience in creating, executing, and delivering outcomes strategies /projects using advanced methods and…